1. Home
  2. FGBI vs ATYR Comparison

FGBI vs ATYR Comparison

Compare FGBI & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Guaranty Bancshares Inc.

FGBI

First Guaranty Bancshares Inc.

HOLD

Current Price

$4.79

Market Cap

73.7M

Sector

Finance

ML Signal

HOLD

Logo aTyr Pharma Inc. Common Stock

ATYR

aTyr Pharma Inc. Common Stock

HOLD

Current Price

$0.83

Market Cap

72.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FGBI
ATYR
Founded
1934
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
73.7M
72.6M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
FGBI
ATYR
Price
$4.79
$0.83
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$8.75
AVG Volume (30 Days)
24.3K
3.3M
Earning Date
11-17-2025
11-06-2025
Dividend Yield
0.91%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$13,036,000.00
$190,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$0.20
$18,728.88
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.31
$0.64
52 Week High
$14.93
$7.29

Technical Indicators

Market Signals
Indicator
FGBI
ATYR
Relative Strength Index (RSI) 36.37 47.53
Support Level $4.31 $0.70
Resistance Level $5.17 $0.86
Average True Range (ATR) 0.31 0.06
MACD 0.06 0.04
Stochastic Oscillator 43.44 81.60

Price Performance

Historical Comparison
FGBI
ATYR

About FGBI First Guaranty Bancshares Inc.

First Guaranty Bancshares Inc provides personalized commercial banking services to its customers in Louisiana, through several banking facilities. The principal business activity of the company includes attracting deposits and investing it together with funds generated from operations and borrowings insecurities and in lending activities to serve the credit needs of its customer base. The company offers commercial real estate loans, commercial and industrial loans, construction and land development loans, agricultural and farmland loans, and to a lesser extent, consumer and multifamily loans.

About ATYR aTyr Pharma Inc. Common Stock

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

Share on Social Networks: